Fuda Cancer Hospital is a specialized tertiary cancer hospital in China, affiliated with Jinan University. The hospital was founded in 2003 by Professor Xu Kecheng and focuses on the treatment of malignant tumors, including at the intermediate and advanced stages.
In 2010, Fuda Hospital received the status of a National Key Clinical Specialty in oncology and accreditation from the Joint Commission International (JCI). The clinic is located in the city of Guangzhou, Guangdong Province, and receives patients from more than 100 countries around the world.
Fuda Hospital specializes in the treatment of various types of malignant tumors, including:
One of the clinic's key areas is the treatment of lung cancer using cryoablation. During the procedure, the tumor is destroyed with ultra-low temperatures via a cryoprobe inserted through the skin. The method is used in patients for whom surgical treatment is contraindicated due to concomitant diseases, age or the location of the tumor. At Fuda Hospital, this procedure has been performed on more than 840 patients with non-small cell lung cancer, including stages III and IV of the disease.
The clinic also has extensive experience in treating advanced liver cancer. Fuda accepts patients who were refused surgery at other medical centers due to the late stage of the disease. One such patient has been followed up without recurrence for more than 16 years after treatment.
Another strong area is the treatment of pancreatic cancer. According to the hospital, the maximum recorded life expectancy of a patient with an advanced stage of this disease after treatment at Fuda was 15 years.
The professional level of Fuda Hospital is confirmed by the results of its clinical work, the introduction of new technologies and its scientific activity. Among them:
The hospital accepts patients of all ages. The youngest patient of the clinic was 11 months old, and the oldest was 93 years old.
The clinic uses more than 20 methods of cancer treatment without traditional surgery or radiation therapy. Among them are several areas in which Fuda has particularly extensive experience.
Short pulses of a high-voltage electric field destroy the cell membranes of malignant cells without heating the surrounding tissues, preserving the nearby vessels, nerves and ducts. This gives a chance of treatment to patients with cancer of the pancreas, liver, kidneys or prostate when the tumor is located near large vessels and surgical intervention is too risky. The procedure for a tumor about 3 cm in size takes approximately 5 minutes.
The method is based on the sequential freezing of tissues down to –160 °C followed by thawing with helium, which leads to the destruction of tumor cells. Thanks to the use of a cryoprobe only 2–4 mm in diameter, the method makes it possible to preserve healthy tissues as much as possible and to minimize blood loss. It is used for tumors of the liver, lungs, kidneys, breast and pancreas. Fuda Hospital has used this technology since 2000 and has already performed more than 10,000 such procedures.
Combined immunotherapy is one of the areas that Fuda Hospital is actively developing. The clinic has conducted more than 15 of its own clinical studies devoted to the use of this method in combination with cryoablation and NanoKnife technology for cancer of the lung, liver, breast, ovaries and other malignant tumors. According to the clinic, this approach makes it possible to reduce the recurrence rate after treatment by up to 50%.
During brachytherapy, microsources with the iodine-125 isotope are inserted into the tumor, providing local irradiation of the affected tissues for approximately 60 days. At Fuda Hospital, this method is combined with cryoablation in the treatment of locally advanced pancreatic cancer. According to the clinic, in 49 patients who underwent such treatment, a control CT scan after 3 months showed a reduction of the tumor or a halt in its growth in almost 90% of cases.
Turning to Fuda Hospital may be advisable in the following clinical situations:
If you are considering treatment at Fuda Cancer Hospital, the specialists of Experts Medical will help you select a suitable doctor, coordinate a treatment program and fully organize the trip to Guangzhou.
Oncology
| Cryoablation (CSA) | from €5400 | Enquire price |
| NanoKnife (irreversible electroporation, IRE) | from €19500 | Enquire price |
| Radiofrequency ablation | from €85 | Enquire price |
| Iodine-125 seed brachytherapy | from €85 | Enquire price |
| CIK immunotherapy | from €4300 | Enquire price |
| PD-1 (checkpoint inhibitors) | from €2600 | Enquire price |
| Combined immunotherapy (CIC) | Enquire price | |
| NK-cell immunotherapy | Enquire price |
| PET-CT | from €1300 | Enquire price |
| Needle biopsy | from €1000 | Enquire price |
| FoundationOne CDx genetic test | from €7700 | Enquire price |
| MRI with contrast | Enquire price |
Specialization:
Education:
Clinical experience:
Languages:
Specialization:
Clinical experience:
Awards and recognition:
Membership in associations:
Specialization:
Education:
Clinical experience:
Membership in associations:
Awards and publications:
Specialization:
Education:
Clinical experience:
Membership in associations:
Minimally invasive techniques:
Awards and recognition:
Specialization:
Education:
Clinical experience:
Specialization:
Education:
Clinical experience:
Membership in associations:
Awards and recognition:
Specialization:
Clinical experience:
Specialization:
Clinical experience:
Position:

we will contact you within 15 minutes